PROLACTIN EXCESS

Clinical trials for PROLACTIN EXCESS explained in plain language.

Never miss a new study

Get alerted when new PROLACTIN EXCESS trials appear

Sign up with your email to follow new studies for PROLACTIN EXCESS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1

Short, strong blitz vs. long, slow fight: new hope for common hormone tumor?

Disease control Recruiting now

This study is testing a new treatment strategy for small, benign pituitary tumors that cause excess prolactin hormone. It compares a short, high-dose course of the standard drug cabergoline (about 6 months) against the usual long-term, low-dose treatment (2 years). The goal is to…

Matched conditions: PROLACTIN EXCESS

Phase: PHASE3 • Sponsor: University of Sao Paulo General Hospital • Aim: Disease control

Last updated Mar 30, 2026 14:33 UTC

PROLACTIN EXCESS

Get alerted when new PROLACTIN EXCESS trials appear

Short, strong blitz vs. long, slow fight: new hope for common hormone tumor?